The board of Neimeth International Pharmaceuticals Plc, on Tuesday announced the appointment of Matthew Obi Azoji as new managing director and chief executive with effect from February 1, 2019.
Azoji, a first class graduate of Pharmacy from the Obafemi Awolowo University, Ile-Ife, Osun State, was until his appointment, CEO of Biovaccines Nigeria Ltd, a public-private partnership company between the Federal Government and May & Baker Nigeria Plc.
A statement issued to the Nigerian Stock Exchange (NSE) by F.T. Onyenekwe (Mrs), company secretary of Neimeth, said Azoji, who also obtained an MBA (Marketing) from the Enugu State University of Science and Technology and Advanced Management Programme from the Lagos Business School, began his professional career as a hospital pharmacist at the General Hospital Saminaka, Kaduna State in 1986 where he undertook the mandatory National Youth Service Corps (NYSC).
He joined May & Baker Nigeria Plc in 1988 and was there until 2004, rising through the ranks from Medical Representative to Assistant Manager- Ethical Product Sales, Area Manager- North, Sales and Market Development Manager, regional Sales Manager- Lagos/South West, Business Manager- Healthcare- Consumer and Head, Corporate Planning and development.
From there, he moved to CHAN Medi-Pharm Ltd/Gte, Jos, Plateau State as pioneer MD/CEO, where he was until September last year.
He was on the boards of Ecumical Pharmaceutical Network (EPN) and the Africa Christian Health Association Platform (ACHAP), both of which are based in Nairobi, Kenya, contributing to enhancing quality pharmaceutical and other health services to both the African people and across the world.
His appointment will however be ratified at the forthcoming annual general meeting of Neimeth Pharmaceuticals.